Pyxis Oncology, Inc.
PYXS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001782223
In the last 90 days, Pyxis Oncology, Inc. insiders filed 1 open-market purchase and 0 sales; 76 institutions reported holding it in 13F filings for Q2 2026, worth $101.1M in total; no superinvestor holds it.
Q3 2023 vs. Q2 2023
How the institutions holding Pyxis Oncology, Inc. changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Of which not filed for Q3 2023 | Q3 2023 | Change |
|---|---|---|---|---|
| Holders | 48 | 1 | 54 | +7 |
| Shares | 9.61M | 708.3K | 7.81M | −1.08M (−12.2%) |
| Value | $24.6M | $1.81M | $15.4M | −$7.33M (−32.2%) |
1 institution that held it in Q2 2023 haven't filed for Q3 2023 yet. Not filing isn't selling, so the changes leave them out.
New holders (14)
Institutions that held Pyxis Oncology, Inc. at the end of Q3 2023 but not at the end of Q2 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Decheng Capital Management III (Cayman), LLC | 326,810 | $650.4K | 0.22% |
| Fan Yu | 69,303 | $137.9K | 9.78% |
| Squarepoint Ops LLC | 22,556 | $44.9K | 0.00% |
| Schulhoff & Co Inc | 22,000 | $43.8K | 0.02% |
| American Century Companies Inc | 13,771 | $27.4K | 0.00% |
| Commonwealth Equity Services, LLC | 12,950 | $26.0K | 0.00% |
| Acadian Asset Management LLC | 13,233 | $26.0K | 0.00% |
| Sawtooth Solutions, LLC | 11,234 | $22.4K | 0.00% |
| Bleakley Financial Group, LLC | 11,234 | $22.4K | 0.00% |
| Tower Research Capital LLC (TRC) | 1,983 | $3.95K | 0.00% |
| Authentikos Wealth Advisory, LLC | 21 | $42 | 0.00% |
| Qube Research & Technologies Ltd | 2 | $4 | 0.00% |
| Radcliffe Capital Management, L.P. | 53,288 | $0 | 0.00% |
| Cutler Group LP | 51 | $0 | 0.00% |
Sold out (7)
Institutions that held Pyxis Oncology, Inc. at the end of Q2 2023 and filed for Q3 2023 without it.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Tang Capital Management LLC | 1,787,775 | $4.58M |
| Goldman Sachs Group Inc | 45,974 | $117.7K |
| Jump Financial, LLC | 31,026 | $79.4K |
| Millennium Management LLC | 30,878 | $79.0K |
| XTX Topco Ltd | 15,236 | $39.0K |
| Centiva Capital, LP | 13,546 | $34.7K |
| The PNC Financial Services Group, Inc. | 100 | $256 |
Not filed for Q3 2023 yet (1)
Institutions that held Pyxis Oncology, Inc. at the end of Q2 2023 and haven't filed a 13F for Q3 2023. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Tekla Capital Management LLC | 708,303 | $1.81M |